Annals of Thoracic Surgery Short Reports
Издатель: Elsevier · ISSN 2772-9931 · 100 статей
-
Quantifying long-term outcomes and risks for living liver donors: a review of the current global experience
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Ashwin Rammohan, Madhukar S. Patel, Ramkiran Cherukuru, Lauren E. Matevish, Dong-Hwan Jung, Parsia A. Vagefi, Mohamed Rela
-
Is FIB-4 the right tool for screening for liver fibrosis?
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Leen J.M. Heyens, Demi P.A. van Malde, Gediz Dogay Us, Francesco Innocenti, Mathieu Struyve, Christophe Van Steenkiste, Sven Francque,...
-
Liver transplant outcomes of deceased donor types following normothermic machine perfusion: A meta-analysis
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Abraham M.P. den Dekker, Alexander Franssen, Ewout W. Steyerberg, Hwai-Ding Lam, Jason B. Doppenberg, Ian P.J. Alwayn
-
Situational panorama of chronic liver diseases: A single-center experience at a university hospital in northeast Mexico (1995–2019)
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Paula Cordero-Perez, Liliana Torres-González, Samuel Rivas-López, Carolina Treviño-García, Airam Regalado-Ceballos, Jaime R....
-
Clinical, etiological, and demographic aspects of cirrhosis in South America: a report from the South American Liver Research Network
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Jhon E. Prieto, Diego R. Puentes, Angelo Z. Mattos, Enrique Carrera E., Javier Diaz Ferrer, Martín Padilla-Machaca, Domingo Balderramo,...
-
Twofold increased risk of coronary artery disease after liver transplantation: A nationwide Swedish cohort of 2925 patients
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Christian Lewinter, Linnea Widman, Michael Melin, Axel Wester, Ying Shang, Hannes Hagström
-
Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS)
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Xiaotong Xu, Tong Zhu, Changyou Jing, Kunlei Zhu, Qinghua Meng, Jianjun Li
-
Liver transplant outcomes in primary biliary cholangitis and metabolic dysfunction-associated steatotic liver disease overlap
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Leandro Sierra, Shahana Prakash, Jamak Modaresi Esfeh, Omar T. Sims, Dian J. Chiang
-
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. cities
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Jeffrey V. Lazarus, Trenton M. White, Melina I. Manolas, Alina M. Allen, Silvana Pannain, Naim Alkhouri, Meena B. Bansal, Michael Charlton,...
-
Can liver biopsy be spared for the diagnosis of autoimmune hepatitis in selected children? A multicenter retrospective study
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Valeria Delle Cave, Fabiola Di Dato, Pier Luigi Calvo, Michele Pinon, Marina Aloi, Francesca Zucconi, Ruggiero Francavilla, Eugenia...
-
Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
-
Association of nonselective β blockers with the development of hepatocellular carcinoma in liver cirrhosis: a meta-analysis
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Yan Xu, Xiaohe Wang, Xiangdong Li, Qingchun Zhao, Xiangbo Xu
-
Nationwide analysis on the impact of the organization of care on the outcomes of perihilar cholangiocarcinoma
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Merve Rousian, Julien A. Luyten, Lydia van der Geest, Stefan Buttner, Maxime Dewulf, Lydi M.W.J. van Driel, Joris Erdmann, Dries Braat,...
-
Relationship between sleep patterns and incident liver related events: retrospective analysis of prospectively collected data from UK Biobank participants
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Xiangxia Zeng, Shijia Wang, Peiting Zhang, Ailan Chen, Hongliang Xue
-
The association of frailty with cardiovascular diseases and mortality in metabolic dysfunction-associated steatotic liver disease
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Fuyi Ma, Huanyu Wang, Kang Wan, Yuan Li, Yuhang Chen, Ru Wang
-
Simple model stratifies liver cancer risk in non-cirrhotic chronic hepatitis C patients after viral eradication
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Yen-Chun Liu, Te-Sheng Chang, Chi-Yi Chen, Ya-Ting Cheng, Yi-Cheng Chen, Yi-Chung Hsieh, Wen-Juei Jeng, Chun-Yen Lin, Rong-Nan Chien,...
-
Screening and management for portal hypertension in hepatocellular carcinoma: A nationwide survey in China
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Xueyan Li, Huiyu Chen, Qingqing Zhang, Shaotong Wang, Youping Wang, Yixuan Chen, Jun Song, Mingkai Chen
-
The role of inpatient palliative care consultation in end-stage liver disease: Too little, too late?
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Neha Wadhavkar, Joao Filipe G. Monteiro, Kanika Malani, Yousef Elfanagely, Kittichai Promrat
-
Development and validation of the HABIT score: a practical and robust tool to predict hepatic steatosis using HbA1c, BMI, and triglycerides in patients with unexplained elevated liver enzymes
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Eike Humbert, Verena Wilkens, Semjon Bugaichuk, Karoline Horvatits, Ansgar W. Lohse, Samuel Huber, Sven Pischke, Thorben Fründt
-
Development and validation of a prediction model for acute kidney injury in cirrhosis with normal serum creatinine levels
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Shenglong Lin, Wenhai Ke, Rong Wang, Huaxi Ma, Ziyuan Liao, Jianyu Wang, Minghua Lin, Haibing Gao
-
Trends of metabolic dysfunction-associated steatotic liver disease in Mexico, 1990–2023: insights from the Global Burden of disease study
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Israel Rico-Alba, Alberto Retana-Guzmán, Marcela Agudelo-Botero, Claudio Alberto Dávila-Cervantes
-
Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Lorenz Balcar, Adrian Wunderbaldinger, Lucie Simonis, Jan Embacher, Stefanie Wilfinger, Lukas Hartl, Mathias Jachs, Benedikt Silvester...
-
The impact of early allograft dysfunction severity on graft and recipient outcomes in pediatric liver transplantation
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Weiming He, Xiaoke Dai, Bingqian Tan, Fumin Zhu, Chao Lv, Chengang Qi, Anrui Wang, Quanhai Zhang, Jiajun Wen, Xiaolei Gao, Mingman Zhang
-
Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Yujie Zhang, Ruoting Men, Yi Shen, Xianglin Wang, Yunke Peng, Xiaoyan Ao, Li Yang, Xiaoli Fan
-
MRI imaging and machine learning based radiomics for detection of mixed HCC and CCA tumors
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Yuquan Qian, Qiao-Yuan Lu, Isaac Rodriguez, Michael Vácha, Xiangde Min, Muzaffer Reha Ümütlü, German A. Castrillon, Andreas Georg Schreyer,...
-
PAI-1 as a modulator of the EMT-associated signaling pathway during HCV protein expression
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Tania G. Heredia-Torres, Alí F. Ruiz-Higareda, Martin G. Garcia-Juarez, Cynthia L. Pecina-Reyes, Blanca E. Alvarez-Salas, Veronica...
-
Longitudinal health-related quality of life and associated factors in autoimmune liver diseases
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Dami Ko, Vilas Patwardhan, Natalia Rojas-Amaris, Victoria Abadi-Ron, Ana Marenco-Flores, Romelia Barba, Esli Medina-Morales, Leandro...
-
A prospective cohort validation study of a multivariable algorithm ASAP for risk stratification of hepatocellular carcinoma surveillance
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Wei-Lun Liou, Si-Yu Tan, Laurel Jackson, Jason Pik-Eu Chang, Thinesh Lee Krishnamoorthy, Claire Chen, Chin-Pin Yeo, Chee-Kiat Tan
-
The absence of the alpha-7 nicotinic acetylcholine receptor impairs liver regeneration due to altered autophagic response after resection
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Franciely Alves Silva, Ana Laura Vieira-da-Silva, Marcos Vinícius Esteca, Suleyma de Oliveira Costa, Priscilla Karla Fernandes Lopes, Igor...
-
Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) without cirrhosis
Publication date: July–December 2026 Source: Annals of Hepatology, Volume 31, Issue 2 Author(s): Hao-Chien Hung, Po-Jung Hsu, Yin Lai, Wei-Chen Lee, Chen-Fang Lee